We are live on
!
Find out more
MIM
Monashee Investment Management Portfolio holdings
AUM
$184M
1-Year Est. Return
197.43%
This Fund
S&P 500
This Quarter
Est. Return
+12.36%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$525M
AUM Growth
+$163M
(+45%)
Cap. Flow
-$365M
Cap. Flow
% of AUM
-69.47%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
251
New
–
Increased
–
Reduced
–
Closed
140
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAGE
Sage Therapeutics
SAGE
|
+$17.3M |
| 2 |
General Mills
GIS
|
+$16.1M |
| 3 |
Hilton Grand Vacations
HGV
|
+$13.9M |
| 4 |
Dominion Energy
D
|
+$13.5M |
| 5 |
Arch Capital
ACGL
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.2% |
| 2 | Financials | 16.74% |
| 3 | Technology | 15.78% |
| 4 | Industrials | 10.99% |
| 5 | Energy | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
General Mills
GIS
$19.7B
| – | – |
-357,400
| Closed | -$16.1M |
|
|
CBIO
177
Crescent Biopharma
CBIO
$626M
| – | – |
-1,400
| Closed | -$175K |
|
178
Guidewire Software
GWRE
$14.2B
| – | – |
-50,000
| Closed | -$4.04M |
|
|
179
Hilton Grand Vacations
HGV
$3.55B
| – | – |
-322,500
| Closed | -$13.9M |
|
180
Hamilton Lane
HLNE
$5.57B
| – | – |
-10,000
| Closed | -$372K |
|
181
Immunic
IMUX
$195M
| – | – |
-35
| Closed | -$96K |
|
182
KKR & Co
KKR
$92.3B
| – | – |
-100,000
| Closed | -$2.03M |
|
183
MacroGenics
MGNX
$257M
| – | – |
-197,500
| Closed | -$4.97M |
|
184
OceanFirst Financial
OCFC
$1.91B
| – | – |
-191,290
| Closed | -$3.34M |
|
185
Okta
OKTA
$25.8B
| – | – |
-10,000
| Closed | -$399K |
|
186
OP Bancorp
OPBK
$233M
| – | – |
-100,000
| Closed | -$1.25M |
|
187
Old Second Bancorp
OSBC
$1.29B
| – | – |
-30,851
| Closed | -$429K |
|
188
Pangaea Logistics
PANL
$485M
| – | – |
-15,041
| Closed | -$1K |
|
189
Progressive
PGR
$125B
| – | – |
-25,000
| Closed | -$19K |
|
190
Park Hotels & Resorts
PK
$2.97B
| – | – |
-370,732
| Closed | -$10M |
|
191
PTC Therapeutics
PTCT
$6.12B
| – | – |
-80,000
| Closed | -$2.17M |
|
192
Arcus Biosciences
RCUS
$3.64B
| – | – |
-154,750
| Closed | -$132K |
|
193
RPC Inc
RES
$1.3B
| – | – |
-50,000
| Closed | -$902K |
|
194
Roku
ROKU
$22.7B
| – | – |
-50,000
| Closed | -$1.55M |
|
195
Rapid7
RPD
$773M
| – | – |
-383,000
| Closed | -$9.79M |
|
|
STG
196
Sunlands Technology
STG
$45.5M
| – | – |
-5,600
| Closed | -$581K |
|
197
TransUnion
TRU
$15.3B
| – | – |
-150,000
| Closed | -$8.52M |
|
198
Unitil
UTL
$980M
| – | – |
-45,000
| Closed | -$2.09M |
|
199
Univest Financial
UVSP
$1.18B
| – | – |
-64,314
| Closed | -$1.78M |
|
200
Vanda Pharmaceuticals
VNDA
$302M
| – | – |
-250,000
| Closed | -$4.21M |
|
Similar funds
SWMG
IFPL
RFG
NAM
GCGM
PSAMP
GCA
IVGAV
Monashee Investment Management's Q2 2018 Portfolio in Review
As of Q2 2018, Monashee Investment Management held 251 positions worth $525M, up 45% from $362M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Monashee Investment Management withdrew a net $365M in Q2 2018, closing 140 positions. Its most notable exit was Sage Therapeutics, an estimated $17.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.
- Monashee Investment Management fully exited Sage Therapeutics in Q2 2018, selling an estimated $17.3M.
- Monashee Investment Management's ten largest holdings make up 35% of its $525M portfolio in Q2 2018.
- Monashee Investment Management opened 0 new positions and closed 140 in Q2 2018.
- Monashee Investment Management's portfolio value rose 45% quarter-over-quarter to $525M.
Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.